To JUPITER and beyond: statins, inflammation, and primary prevention
- PMID: 20497597
- PMCID: PMC2911709
- DOI: 10.1186/cc9006
To JUPITER and beyond: statins, inflammation, and primary prevention
Comment on
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997196 Clinical Trial.
References
-
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207. doi: 10.1056/NEJMoa0807646. - DOI - PubMed
-
- Slejko J, Page RL, Sullivan PW. Statin therapy is cost-effective for vascular event prevention in adults with elevated C-reactive protein: Implications of JUPITER [abstract] J Am Coll Cardiol. 2010;55:A131.E1229. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical